PharmaJet

Vaccine delivery to the skin using PharmaJet® Tropis® ID  was preferred by more than 98% of parents and healthcare staff and results in 50% fewer adverse events! Reach out to us if you want to explore how needle-free can make your injectable candidate better!

Vaccine recently published a study conducted in Cuba that highlights significantly fewer adverse events with Tropis ID administration compared to needle and syringe (N/S). Intradermal administration with N/S is relatively uncomfortable and complex and requires specific training. Tropis ID offers an easy-to-use, reliable intradermal delivery solution that was preferred by over 98% of parents and nurses. You can read the release here: https://lnkd.in/gpmkNxbd

If you're attending the World Vaccine Congress 2025, we invite you to come to the PharmaJet presentation on April 23 where we will share partner data demonstrating how needle-free delivery boosts immune response of DNA and novel therapeutic cancer vaccines. Find out more here: https://lnkd.in/gtE4euAg

We're looking forward to the World Vaccine Congress next week. Dan Mallon, our Sr. Vice President of Corporate Development, will be delivering a pre-conference presentation entitled "Navigating the Immune System starts with Precise Delivery". The presentation, on April 21, is part of the Vaccine Delivery session from 2:00 - 5:00 PM in Room 202A. Hope to see you there!

We are pleased to announce the post hoc Phase 3 clinical trial analysis published in npj Vaccines reporting a broad and long-lasting immune response when Tropis ID was used to administer a samRNA COVID-19 vaccine booster. The analysis showed robust and durable memory B-cell and T-cell responses and induced antibody responses that are cross-reactive towards several SARS-CoV-2 strains. https://lnkd.in/gANj3ADF

Technet is a global network of immunization professionals established by WHO and UNICEF and committed to strengthening immunization services. PharmaJet is highlighted in their latest Global Immunization Network newsletter! Check it out! Study in Nigeria shows needle-free injection of IPV is effective at increasing coverage, decreasing program costs, and is feasible for routine immunization use. https://lnkd.in/gCnT7qFQ> 

Technet is a global network of immunization professionals established by WHO and UNICEF and committed to strengthening immunization services. PharmaJet is highlighted in their latest Global Immunization Network newsletter! Check it out! Study in Nigeria shows needle-free injection of IPV is effective at increasing coverage, decreasing program costs, and is feasible for routine immunization use. https://lnkd.in/gCnT7qFQ> 

Earlier this month, PharmaJet Regional Director of Africa, Kang'ethe Ngure, presented a donation of Tropis Intradermal Needle-free System supplies to the National Primary Health Care Development Agency (NPHCDA) to support polio immunization. The handover ceremony was presided over by Dr. Rufai, Director of Disease Control (Representing the Executive Director of NPHCDA). The PharmaJet team is proud to continue supporting Polio Eradication!

https://lnkd.in/gEsSQ5Hd

We are pleased to share that Tropis ID was used to immunize an additional 1.5 million children in the latest WHO polio eradication campaign in Pakistan. In total, Tropis has been used in campaigns and routine immunizations to protect nearly 12 million children against poliovirus. https://lnkd.in/gURDuFaU